Long-term trends in the incidence of heart failure after myocardial infarction. - Wikidata - awgldk - TriplyDB

Long-term trends in the incidence of heart failure after myocardial infarction.

Long-term trends in the incidence of heart failure after myocardial infarction.

http://www.wikidata.org/entity/Q37312662

about

Stem cell treatment for acute myocardial infarction Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction Epidemiology and risk profile of heart failure Heart failure as a general pandemic in Asia Targeting interleukin-1 in heart disease Getting to the heart of intracellular glucocorticoid regeneration: 11β-HSD1 in the myocardium Localization of Islet-1-positive cells in the healthy and infarcted adult murine heart Development of a closed chest model of chronic myocardial infarction in Swine: magnetic resonance imaging and pathological evaluation.Influence on prognosis and prevalence of stress hyperglycemia in a cohort of patients with acute coronary syndrome.Cell-based therapy for heart disease: a clinically oriented perspective Heart failure after myocardial infarction in the era of primary percutaneous coronary intervention: Mechanisms, incidence and identification of patients at risk Potency of Human Cardiosphere-Derived Cells from Patients with Ischemic Heart Disease Is Associated with Robust Vascular Supportive Ability.Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure.Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries.Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes.Blood vessel repair and regeneration in the ischaemic heart Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction.The aging heart and post-infarction left ventricular remodeling.Bone marrow characteristics associated with changes in infarct size after STEMI: a biorepository evaluation from the CCTRN TIME trial.Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.National trends in recurrent AMI hospitalizations 1 year after acute myocardial infarction in Medicare beneficiaries: 1999-2010.Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.Left ventricular remodeling in swine after myocardial infarction: a transcriptional genomics approach.Secretome of apoptotic peripheral blood cells (APOSEC) confers cytoprotection to cardiomyocytes and inhibits tissue remodelling after acute myocardial infarction: a preclinical study.The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse.Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion.Microfluidic Single-Cell Analysis of Transplanted Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes After Acute Myocardial Infarction Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease Bariatric Surgery can Lead to Net Cost Savings to Health Care Systems: Results from a Comprehensive European Decision Analytic Model.Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation.Infarct healing is a dynamic process following acute myocardial infarction.Natural IgM Blockade Limits Infarct Expansion and Left Ventricular Dysfunction in a Swine Myocardial Infarct Model Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.Intracoronary Transplantation of Mesenchymal Stem Cells with Overexpressed Integrin-Linked Kinase Improves Cardiac Function in Porcine Myocardial Infarction.Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT)Luteolin alleviates post-infarction cardiac dysfunction by up-regulating autophagy through Mst1 inhibition Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction.Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury

P2860

Q24186920-D2AF7A08-E681-40DE-BEB4-566CB3721027 Q24314350-66CD61E5-79C3-4812-B5FE-8A6E1D29A6A4 Q24630778-E9C986A9-C983-4F91-93B8-B2E08C0AB894 Q26801810-4049AB78-4768-45AC-8172-09CCDF0AA15A Q27009347-16F7AA67-C9E6-410D-BBE5-33D9150EE655 Q28067162-B85FD56D-E5BB-4276-864A-9AC987B24580 Q28262163-2EBF71BC-3362-4746-BDDC-97323B41AB00 Q30557205-832DB886-8D49-433E-96B0-8FD4B6518E58 Q33653141-C8BA65DC-82B1-449B-8D06-3E4F12EEB21B Q33713519-EC0C72CC-F50D-415F-98C6-4C3156E9221E Q33721171-40B1EC09-A06C-4DFC-9045-CA8C455FDD93 Q33722072-1CA099D2-418B-4E84-AB02-C3103A0C3CC0 Q34081522-836CD08B-ECA7-4A87-86FE-2009BF359028 Q34162294-EE2DB9BA-4C6D-4275-8827-504C846EEF90 Q34288961-74BFFE2B-3D19-4DDF-8463-3241B90D9627 Q34304413-B79C5CB1-DE7D-447A-B748-A18373203BAE Q34350298-257FEED5-7989-4196-BEF8-256A3B1E6E44 Q34532985-45A52E76-47AA-4531-932C-AE0AE16C6740 Q34542195-F06A98F7-D301-4E6C-BC90-E5E89F4DA4F5 Q34807168-F3669E7B-8F5C-4977-9E0A-02A11A872A3D Q35017285-5345EC79-1580-4D36-9703-87341E668651 Q35070720-3F8F5E2D-8025-4FFA-BAB7-FDE1BFF8D534 Q35193931-C856B5B6-4367-4EA1-99FC-5F2C1B4E571C Q35556751-A02FE03F-0C18-4291-9D63-05ADB800D969 Q35587392-736DC97E-4A63-46F2-9B42-765407C24F63 Q35587397-C89AF81A-0C8A-4166-9D99-BD5DFDFB028F Q35621283-43363313-19A8-4680-9A0B-8AF127C8DFE7 Q35648006-DFAAA916-A670-4537-8E7C-4C20A7125B77 Q35754348-4E080483-B8CB-49D4-BC76-D78B591D85BC Q35804026-F4655457-91C3-4C80-B0F4-DA3E662EA7D5 Q35907975-B53C63D7-8681-4B78-BCB6-9DDE55A25327 Q36233665-FC57F96F-F2F4-488C-BF4D-208E70D17626 Q36237173-873ACCFD-5576-49B3-8AFD-761BB24B735E Q36394858-49C4CCE7-87FF-437C-B97B-C98532A4FF2A Q36407129-F6FAE700-4D4D-47E5-AC5C-17E6E50CD5F7 Q36448909-E962E3FB-B2BE-4C7E-81F5-8D1F4909561A Q36455475-241D9293-715A-43C5-BB1C-61D5D6DCA802 Q36476858-7F01EF3F-97E2-444E-B6CB-3580F8669077 Q36522680-AEA3B4E9-6382-4FFF-9A15-2A7C2B3E04F6 Q36596197-EBD5563D-2E96-4800-987A-805AF918B96D

P2860

Long-term trends in the incidence of heart failure after myocardial infarction.

http://www.wikidata.org/entity/Q37312662

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Long-term trends in the incidence of heart failure after myocardial infarction.

@en

Long-term trends in the incidence of heart failure after myocardial infarction.

@nl

type

label

Long-term trends in the incidence of heart failure after myocardial infarction.

@en

Long-term trends in the incidence of heart failure after myocardial infarction.

@nl

prefLabel

Long-term trends in the incidence of heart failure after myocardial infarction.

@en

Long-term trends in the incidence of heart failure after myocardial infarction.

@nl

P1433

Q37312662-C72D7610-187B-4389-8E3C-0A12CEA58264

P1476

Q37312662-7B2E681E-2A20-406E-A0A6-A5D076F26FEA

P2093

Q37312662-2A71CCA8-54AF-45AB-9491-C1D11540CE75

Q37312662-597F251B-6F38-42B9-8934-90A493F276C4

Q37312662-5C83DC06-8720-48B6-A542-FA50AF819011

Q37312662-85D8AFC4-3D90-4533-AB8E-3B3C2E9B0DFD

Q37312662-DAE173E4-33C8-46C4-875C-7A5B327F434C

Q37312662-E36D319A-88EC-40FB-A54E-A31B6B39D7C0

P2860

Q37312662-046E94C9-DB8B-4D9F-AECA-F8D3E6C3F648

Q37312662-135AEC55-0944-4E7D-A5E4-DB95C2135BE4

Q37312662-2C403AA5-C459-4555-97FE-2FD5198BE10C

Q37312662-3F598A0C-76FB-4A51-8D48-4A54243CC115

Q37312662-46C39D18-9CF5-4A2B-837F-B473ADD6F6CE

Q37312662-5212868A-8E70-4941-8D49-51A3E452AA27

Q37312662-55A4AB3C-CD6F-4A6F-893F-C75ABF9E5768

Q37312662-5E32D23C-6848-4576-B831-8076ABD77F7C

Q37312662-602B078E-E178-4A53-8FC0-26EF4B0AFFD9

Q37312662-6C61804B-EECE-4746-8068-CBEEE7F5B65F

P304

Q37312662-6334ABDB-1E02-491E-9F43-5CF326429378

P31

Q37312662-07E4AA81-8B8B-400A-AEAE-C9665E85DC2F

P356

Q37312662-859DC467-E8F0-40BB-9DF1-3D6F50C7EC09

P407

Q37312662-F70E47F9-1046-48A3-AA41-D01CA74C5BB7

P433

Q37312662-4494663A-4D87-4AD6-8951-6E55FDCF7BB4

P478

Q37312662-ABBF7E42-D35C-45FB-A385-7AA05D8A186D

P50

Q37312662-17605727-9C86-46B5-B374-EB59F1FC0074

Q37312662-5365899A-AAAD-464B-8245-A76757D7594E

Q37312662-EE7D3962-CCCE-4793-9C90-9C60D8AE4D17

P577

Q37312662-9FF9DBEE-6366-41C9-9465-EE6DFC4EC8D5

P698

Q37312662-23DBB02B-EBC2-4F76-8FBF-61F698F8A211

P921

Q37312662-D430A3E1-6EA7-4DAA-8BC6-1814120E0636

Q37312662-F0BC5006-ADE2-4CBD-A1E8-C9DB3F02BE05

P932

Q37312662-390B6DB7-F76C-42C6-AB73-82031D673B0C

P356

CIRCULATIONAHA.108.784215

P1433

P1476

Long-term trends in the incidence of heart failure after myocardial infarction.

@en

P2093

Daniel Levy

http://www.w3.org/2001/XMLSchema#string

Nisha I Parikh

http://www.w3.org/2001/XMLSchema#string

Raghava S Velagaleti

http://www.w3.org/2001/XMLSchema#string

Ralph B D'Agostino

http://www.w3.org/2001/XMLSchema#string

Thomas J Wang

http://www.w3.org/2001/XMLSchema#string

William B Kannel

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.

Incidence of heart failure after myocardial infarction: is it changing over time?

Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study.

Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

The natural history of congestive heart failure: the Framingham study.

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.

Epidemiology of myocardial infarction.

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Chronic heart failure in the United States: a manifestation of coronary artery disease.

P304

2057-2062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCULATIONAHA.108.784215

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Ramachandran S. Vasan

Michael J Pencina

Joanne M Murabito

P577

2008-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18955667

http://www.w3.org/2001/XMLSchema#string

P921

P932

2729712

http://www.w3.org/2001/XMLSchema#string